137 related articles for article (PubMed ID: 9497876)
1. Demonstration of fragments with thyroid stimulating activity from thyroid stimulation blocking antibodies-IgG molecules by papain digestion.
Kouki T; Inul T; Yamashiro K; Hachiya T; Ochi Y; Kajita Y; Takasu N; Sato Y; Nagata A
Clin Endocrinol (Oxf); 1997 Dec; 47(6):693-8. PubMed ID: 9497876
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of thyroactive smaller components released from TSAb-IgG by protease digestion.
Ogura M; Kouki T; Inui T; Hachiya T; Ochi Y; Kajita Y
Thyroid; 1995 Dec; 5(6):449-54. PubMed ID: 8808094
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of thyroid stimulating activity within H chain fragments of TSAb-IgG by protease digestion and reduction.
Kouki T; Inui T; Hachiya T; Okabe H; Ochi Y; Kajita Y
Clin Endocrinol (Oxf); 1997 Feb; 46(2):183-8. PubMed ID: 9135700
[TBL] [Abstract][Full Text] [Related]
4. Polyethylene glycol augments thyroid cAMP responses by fragments from protease-digested TSAb or TSBAb-IgG.
Yamashiro K; Takasu N; Inui T; Kouki T; Ochi Y; Kajita Y; Sato Y; Nagata A
Life Sci; 1999; 64(13):1109-16. PubMed ID: 10210273
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune hypothyroidism and hyperthyroidism in patients with Turner's syndrome.
Chiovato L; Larizza D; Bendinelli G; Tonacchera M; Marinó M; Mammoli C; Lorini R; Severi F; Pinchera A
Eur J Endocrinol; 1996 May; 134(5):568-75. PubMed ID: 8664977
[TBL] [Abstract][Full Text] [Related]
6. Immunological similarity of thyroid stimulating antibody (TSAb) and thyroid blocking antibody (TBAb) with animal IgG.
Ochi Y; Kajita Y; Hachiya T; Hamaoki M
Endocr J; 2012; 59(1):73-9. PubMed ID: 22082835
[TBL] [Abstract][Full Text] [Related]
7. Lesson from inappropriate TSH-receptor antibody measurement in hypothyroidism: case series and literature review.
Jannin A; Peltier L; d'Herbomez M; Defrance F; Marcelli S; Ben Hamou A; Humbert L; Wémeau JL; Vantyghem MC; Espiard S
Clin Chem Lab Med; 2019 Aug; 57(9):e218-e221. PubMed ID: 30849043
[No Abstract] [Full Text] [Related]
8. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.
Kung AW; Lau KS; Kohn LD
Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257
[TBL] [Abstract][Full Text] [Related]
9. The mechanism involved in the conversion of thyrotropin receptor-bound blocking-type immunoglobulin G (IgG) to the stimulating-type by anti-human IgG antibodies.
Taniguchi S; Yoshida A; Shigemasa C; Mitani Y; Ueta Y; Urabe K; Mashiba H
Endocrinology; 1990 Feb; 126(2):796-803. PubMed ID: 2153526
[TBL] [Abstract][Full Text] [Related]
10. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.
Ochi Y; Kajita Y; Hamazu M; Nagata A
Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785
[TBL] [Abstract][Full Text] [Related]
11. Circulating thyroid antibodies in congenital hypothyroidism.
Ilicki A; Larsson A; Karlsson FA
Acta Paediatr Scand; 1991; 80(8-9):805-11. PubMed ID: 1659767
[TBL] [Abstract][Full Text] [Related]
12. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
13. Antibodies that block stimulation by TSH or TSAb of thyroid hormone secretion in primary hypothyroidism.
Steel NR; Taylor JJ; Holcombe M; Weightman DR; Kendall-Taylor P
Autoimmunity; 1988; 1(2):81-90. PubMed ID: 2908763
[TBL] [Abstract][Full Text] [Related]
14. In-vitro conversion of blocking type anti-TSH receptor antibody to the stimulating type by anti-human IgG antibodies.
Amino N; Watanabe Y; Tamaki H; Iwatani Y; Miyai K
Clin Endocrinol (Oxf); 1987 Nov; 27(5):615-24. PubMed ID: 2897263
[TBL] [Abstract][Full Text] [Related]
15. Separation method of IgG fragments using protein L.
Kouki T; Inui T; Okabe H; Ochi Y; Kajita Y
Immunol Invest; 1997 Jun; 26(4):399-408. PubMed ID: 9246561
[TBL] [Abstract][Full Text] [Related]
16. The IgG subclass distribution of TSH receptor blocking antibodies in primary hypothyroidism.
Kraiem Z; Cho BY; Sadeh O; Shong MH; Pickerill P; Weetman AP
Clin Endocrinol (Oxf); 1992 Aug; 37(2):135-40. PubMed ID: 1395064
[TBL] [Abstract][Full Text] [Related]
17. Role of thyroid-stimulating blocking antibody in patients who developed hypothyroidism within one year after 131I treatment for Graves' disease.
Yoshida K; Aizawa Y; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Nakazato N; Tani J; Abe K
Clin Endocrinol (Oxf); 1998 Jan; 48(1):17-22. PubMed ID: 9509063
[TBL] [Abstract][Full Text] [Related]
18. High prevalence and little change in TSH receptor blocking antibody titres with thyroxine and antithyroid drug therapy in patients with non-goitrous autoimmune thyroiditis.
Cho BY; Kim WB; Chung JH; Yi KH; Shong YK; Lee HK; Koh CS
Clin Endocrinol (Oxf); 1995 Oct; 43(4):465-71. PubMed ID: 7586622
[TBL] [Abstract][Full Text] [Related]
19. Transient neonatal hypothyroidism: characterization of maternal antibodies to the thyrotropin receptor.
Zakarija M; McKenzie JM; Eidson MS
J Clin Endocrinol Metab; 1990 May; 70(5):1239-46. PubMed ID: 1970827
[TBL] [Abstract][Full Text] [Related]
20. Negative correlation between the conversion of thyrotropin receptor-bound blocking type thyrotropin receptor antibody to the stimulating type by anti-human IgG antibodies and the biological activity of blocking type thyrotropin receptor antibody.
Cho BY; Shong MH; Chung JH; Lee HK; Koh CS; Min HK
J Korean Med Sci; 1993 Oct; 8(5):355-60. PubMed ID: 7905742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
